Urs Cadruvi becomes new hospital manager of the Hirslanden hospitals Klinik Stephanshorn and Klinik Am Rosenberg

Urs Cadruvi (49) has been the Hospital Manager of Schiers Hospital, which covers a broad medical spectrum in inpatient and outpatient healthcare, since 2017. Under his leadership, the hospital has continued to grow and expand its medical services. The repositioning of vascular medicine and automation in logistics also fall within his term of office.

Before working in the hospital sector, Urs Cadruvi was Secretary General of the Lia Rumantscha, the umbrella organisation for the Romansh language and culture, for 10 years. Before that, he worked in various positions at the University of Applied Sciences (HTW) in Chur from 1999 to 2007, most recently as head of studies for the Executive Master of Business Administration in General Management programme. From 1998 to 1999 he was also an organisational consultant at the Graubündner Kantonalbank in Chur.

Urs Cadruvi studied business administration at the University of Applied Sciences in Chur, now the University of Applied Sciences of the Grisons. He is currently pursuing a Doctor of Business Administration (DBA) at the C. H. Warsaw Management University.

Further expansion of integrated care

As of 1 November 2022, Urs Cadruvi will take over the management of the Hirslanden Klinik Stephanshorn in St. Gallen and the Hirslanden Klinik Am Rosenberg in Heiden. The two hospitals are currently being managed on an interim basis by Rolf Gilgen after Andrea Rütsche decided to hand over the directorship after 11 years.

Urs Cadruvi will continue the expansion of the existing cross-cantonal, interdisciplinary medical network in order to provide the population of eastern Switzerland with a comprehensive range of services along the entire care and treatment pathway: From prevention to aftercare, outpatient and inpatient − at any time, both on a physical and digital level.

Stéphan Studer, Chief Operating Officer of the Hirslanden Group, had this to say: "We are very pleased to have been able to persuade Urs Cadruvi to join Hirslanden. We are convinced that his proven experience as a hospital manager, his understanding of network-oriented organisations and his knowledge in the field of organisational development make him exactly the right person for the prudent further development of our eastern Switzerland care region."

In addition to the two hospitals, Hirslanden operates the OPERA St. Gallen outpatient surgical centre and a medical centre in eastern Switzerland. In June 2022, a comprehensive outpatient service will also open its doors at the Neudorf Center in St. Gallen, offering radiology diagnostics and outpatient radiotherapy in addition to numerous doctors’ practices.

About Hirslanden

Hirslanden is committed to high-quality, responsible and efficiently integrated healthcare that focuses on the needs of the individual. Working together with private and public cooperation partners, the Hirslanden Group prioritises ongoing development of the Continuum of Care concept. From birth to old age, from prevention to healing, Hirslanden is always there, both on a physical and digital level.

Hirslanden differentiates itself from the rest of the market as a service provider with first-class medical and service quality, which is guaranteed by highly qualified independent specialists with years of experience who offer excellent care and services. Interdisciplinary medical centres of expertise, specialised institutes and competent cooperation partners enable optimal, personalised diagnosis and treatment, regardless of case complexity, in both inpatient and outpatient contexts.

The Hirslanden Group operates 17 hospitals in 10 cantons, many of which have an emergency department. It also operates 4 outpatient surgery centres, 18 radiology and 5 radiotherapy institutes. The Group has 2,314 partner doctors and 10,711 employees, 479 of whom are permanently employed doctors. Hirslanden is the largest medical network in Switzerland. In the 2020/21 financial year, the Group generated a turnover of CHF 1,796 million (including CHF 12.6 million in cantonal COVID-19 compensation payments). As at 31 March 2021, the Group had treated 107,401 patients for a total of 461,004 inpatient days. The patient mix consists of 51 % patients with basic insurance, 28.8 % with semi-private insurance and 20.2 % with private insurance. The Hirslanden Group was formed in 1990 through the merger of several hospitals. Since 2007, it has been part of the international hospital group Mediclinic International plc, which is listed on the London Stock Exchange.